ANIP ANI PHARMACEUTICALS INC

NEUTRAL Impact: 4/10 Insider Cluster (2 insiders)
Horizon weeks Filed May 11, 2026 Processed 1mo ago
Insider cluster: 2 insiders, $4.6M total
Latest settled — T+5d
ANIP ▲ +0.80% at T+5d
NEUTRAL call ✓ call won +0.80% · α vs SPY +0.89% · entry $78.71 → $79.34
Next anchor: T+20d due 5d ago
Currently $81.68 · +3.77% from $78.71 entry
Entry anchored
May 8, 03:59 PM ET
via Databento tick
T+1d
+1.00%
call +1.00% · α +1.14%
$79.50
settled 5w ago
T+5d
+0.80%
call +0.80% · α +0.89%
$79.34
settled 29d ago
T+20d
call — · α —
due 5d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.

Key Financial Metrics

Direction
selling
Total Value
$5.7M
Insiders
2

Actionable Insight

A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.

Key Facts

  • CEO Nikhil Lalwani sold 55,000 shares for $4.27M on May 11, 2026.
  • Director Patrick Walsh sold a total of ~14,000 shares for $1.13M over May 11-13.
  • Total insider sales in the cluster: ~$5.7M, or ~0.3% of ANIP's $1.8B market cap.
  • Q1 2026 revenue was $237.5M (+20.5% YoY), beating consensus of $207.6M.
  • GAAP diluted EPS of $1.28 beat consensus of $1.30.
  • Company raised full-year 2026 guidance and authorized a $100M buyback.
  • Prior 30-day insider activity showed $5.7M in total sales before this cluster.
  • Historical calibration shows score-6 reports in this segment have only a 29% win rate at T+20.

Financial Impact

Insider sales of ~$5.7M represent 0.3% of market cap — modest but concentrated in CEO and director.

dilutioninsider sentiment

Risk Factors

  • CEO selling a large portion of his stake could signal peak valuation or upcoming headwinds.
  • Cluster sales may be followed by more insider selling if the stock continues to rally.
  • Historical calibration suggests score-6 reports in this segment have poor predictive accuracy (29% win rate at T+20).

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ANIP-1778718158958
13 reports for ANIP
Performance horizon
40% Hit rate 2 of 5 directional calls best @ T+20▲ +7.11%Apr 8, 2026
Filters
Rows
Reports for ANIP — sortable, filterable
Type Now
Jun 11, 2026
2d ago
Insider Cluster
NEUTRAL ★ 3/10
$81.77 awaiting T+5awaiting T+5$81.68 (−0.11%)
May 21, 2026
22d ago
8-K
NEUTRAL ★ 3/10
$82.72 $76.71▼ −7.27%▼ −8.92%$81.68 (−1.26%)
May 13, 2026
4w ago
8-K
BULLISH ★ 7/10
$80.88 $80.32▼ −0.69%▲ +0.47%$81.68 (+0.99%)
May 11, 2026
4w ago
Insider Cluster
NEUTRAL ★ 4/10
$78.71 $79.34▲ +0.80%▲ +0.89%$81.68 (+3.77%)
May 8, 2026
5w ago
8-K
BULLISH ★ 8/10
$81.86 $79.58▼ −2.79%▼ −4.25%$81.68 (−0.22%)
May 8, 2026
5w ago
Press Release
BULLISH ★ 8/10
$81.86 $79.58▼ −2.79%▼ −4.25%$81.68 (−0.22%)
Apr 24, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$78.64 $79.45▲ +1.03%▲ +0.12%$81.68 (+3.87%)
Apr 8, 2026
9w ago
Press Release
BULLISH ★ 7/10
$79.01 $76.48▼ −3.20%▼ −6.72%$81.68 (+3.38%)
Apr 7, 2026
9w ago
8-K
NEUTRAL ★ 4/10
$79.01 $76.48▼ −3.20%▼ −6.72%$81.68 (+3.38%)
Apr 7, 2026
9w ago
Press Release
NEUTRAL ★ 4/10
$79.47 $78.29▼ −1.48%▼ −6.81%$81.68 (+2.78%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (49h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access